Findings

What do systematic reviews say?

2 questions · 3 findings · 1 reviews · Gut

No studies found 1 · 33.3%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 33.3%High 1 · 33.3%

Failure to maintain remission · Participants with Crohn's disease in remission

Adalimumab leads to lower failure to maintain clinical remission compared with placebo (high certainty).

2 findings from 1 review

Adalimumab for maintenance of remission in Crohn's disease 2020 · Cochrane Headline outcomes only
RR 0.7 [0.64, 0.77]
3 studies · 683 participants
High
Adalimumab for maintenance of remission in Crohn's disease 2020 · Cochrane Headline outcomes only
RR 0.66 [0.52, 0.83]
2 studies · 554 participants
Moderate

Failure to maintain remission · People with quiescent Crohn's disease (ileocolic resection)

The review found no eligible studies for this question.

1 finding from 1 review

Adalimumab for maintenance of remission in Crohn's disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found